Subscribe

Subgen AI AB (SUBGEN.ST)

SEK0.07 +0.00 (+4.06%)
SE STO Healthcare Medical - Specialties
Address 1 Bow Churchyard EC4M 9DQ
London, SE
CEO Lorenzo Serratosa Gallardo
Website subgen.ai
IPO 2025-12-10
ISIN SE0026820854

Explore sections of this company profile

Also trades on Stockholm Stock Exchange · AEGIR.ST (SEK) Stockholm Stock Exchange · SUBGEN.ST (SEK)
Description

Subgen AI AB develops artificial intelligence-based models and applications to control data for government and businesses. The company engages in the provision of information society services aimed at delivering financial and related knowledge tools to facilitate third-party access to financial literacy and instruments that enable them to interpret such information through e-learning; the acquisition, ownership, management and administration of securities; and the acquisition, ownership, marketing, leasing and operation of rural or urban properties. It also provides financial intermediation services; computer programming activities, structure and content design, writes computer code for systems, computer software, databases and web pages; and customizes computer programs, including configuration and modification of legacy programs. In addition, the company offers marketing and after-sales services of diagnostic imaging machinery and human resources services, as well as development of state-of-the-art artificial intelligence (Al) systems. Further, it provides Serenity Star, AI4D core, and Substrate Cloud. The company is based in London, United Kingdom. Subgen AI AB operates as a subsidiary of Substrate Artificial Inteligence, S.A.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SEK0.07 +0.00 (+4.06%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
21M
Beta
2.69
Float Shares
1.52M
Free Float %
57.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-17.53% +9.48% +81.95% -60.31% -93.83% -87.16% -93.83% -92.65% -99.86% -98.79% -98.79%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.07
Quality scores
Altman Z-Score
-0.50
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Specialties: +8.3%
  • EPS growth Medical - Specialties: +10.1%
    -252.3% Q1'26: +99.3% (vs Q3'24)
  • FCF margin FCF growth · Medical - Specialties: +51.3%
    -75.2% Q1'26: +63.8% (vs Q3'24)
  • EBIT margin Medical - Specialties: +12.6%
    -63.2% Q1'26: -50.0% (vs Q3'24)
  • ROIC Medical - Specialties: +6.6%
    -25.7% Q1'26: -12.8% (vs Q3'24)
  • Share dilution Medical - Specialties: 0.0%
    -49.8% Q1'26: +2,777.8% (vs Q3'24)
  • Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×
    -0.98× Q1'26: -4.51× (vs Q3'24)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (2.56) × ERP
WACC = 0% × Ke + 100% × Kd (16.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.07
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-28 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-27 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-26 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-25 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-22 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-21 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-20 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-19 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-18 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-05-15 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-13 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-12 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-11 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-08 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-07 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-06 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-05 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-04 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-30 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-29 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-28 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-27 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-24 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-04-23 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-04-22 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-04-21 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-04-20 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-04-17 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5
2026-04-16 C 2/5 1/5 1/5 1/5 1/5 1/5 5/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
22.57M
OE per share TTM
-3.54
Owner's Yield
17.45%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
9.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-8.61M
Shares Outstanding
2.65M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Bren Worth Chief Technology Officer male
Carmen Damia C.M.O. female
David Jimenez Chief Financial Officer male
Leandro Daniel Harillo CPO of Serenity Star & Board Member male
Lorenzo Serratosa Gallardo CEO & Director male
Marta Gomez Administration Manager female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits